Show PDB file:   
         Plain Text   HTML   (compressed file size)
QuickSearch:   
by PDB,NDB,UniProt,PROSITE Code or Search Term(s)  
(-)Asym./Biol. Unit - manually
(-)Asym./Biol. Unit
(-)Asym./Biol. Unit - sites
collapse expand < >
Image Asym./Biol. Unit - manually
Asym./Biol. Unit - manually  (Jmol Viewer)
Image Asym./Biol. Unit
Asym./Biol. Unit  (Jmol Viewer)
Image Asym./Biol. Unit - sites
Asym./Biol. Unit - sites  (Jmol Viewer)

(-) Description

Title :  DISCOVERY OF A NOVEL HYDROXY PYRAZOLE BASED FACTOR IXA INHIBITOR
 
Authors :  B. A. Katz
Date :  05 Jan 06  (Deposition) - 04 Apr 06  (Release) - 24 Feb 09  (Revision)
Method :  X-RAY DIFFRACTION
Resolution :  1.95
Chains :  Asym./Biol. Unit :  H,L,T
Keywords :  Active Site-Directed, Short Hydrogen Bond-Mediated, Pyrazole-Based Inhibitor, Hydrolase/Blood Clotting Complex (Keyword Search: [Gene Ontology, PubMed, Web (Google))
 
Reference :  D. Vijaykumar, P. A. Sprengeler, M. Shaghafi, J. R. Spencer, B. A. Katz, C. Yu, R. Rai, W. B. Young, B. Schultz, J. Janc
Discovery Of Novel Hydroxy Pyrazole Based Factor Ixa Inhibitor.
Bioorg. Med. Chem. Lett. V. 16 2796 2006
PubMed-ID: 16487703  |  Reference-DOI: 10.1016/J.BMCL.2006.01.123
(for further references see the PDB file header)

(-) Compounds

Molecule 1 - COAGULATION FACTOR VII
    ChainsL
    EngineeredYES
    Expression SystemESCHERICHIA COLI
    Expression System Taxid562
    FragmentLIGHT CHAIN, RESIDUES 61-212
    GeneF7
    Organism CommonHUMAN
    Organism ScientificHOMO SAPIENS
    Organism Taxid9606
 
Molecule 2 - COAGULATION FACTOR VII
    ChainsH
    EngineeredYES
    Expression SystemESCHERICHIA COLI
    Expression System Taxid562
    FragmentHEAVY CHAIN, RESIDUES 213-466
    GeneF7
    Organism CommonHUMAN
    Organism ScientificHOMO SAPIENS
    Organism Taxid9606
 
Molecule 3 - TISSUE FACTOR
    ChainsT
    EngineeredYES
    Expression SystemESCHERICHIA COLI
    Expression System PlasmidPET-21A(+)
    Expression System StrainBL21-DES3
    Expression System Taxid562
    Expression System Vector TypePLASMID
    FragmentRESIDUES 34-251
    GeneF3
    Organism CommonHUMAN
    Organism ScientificHOMO SAPIENS
    Organism Taxid9606
    SynonymTF, COAGULATION FACTOR III, THROMBOPLASTIN, CD142 ANTIGEN

 Structural Features

(-) Chains, Units

  123
Asymmetric/Biological Unit HLT

Summary Information (see also Sequences/Alignments below)

(-) Ligands, Modified Residues, Ions  (1, 1)

Asymmetric/Biological Unit (1, 1)
No.NameCountTypeFull Name
16NH1Ligand/Ion2-(4-HYDROXY-5-PHENYL-1H-PYRAZOL-3-YL)-1H-BENZOIMIDAZOLE-5-CARBOXAMIDINE

(-) Sites  (1, 1)

Asymmetric Unit (1, 1)
No.NameEvidenceResiduesDescription
1AC1SOFTWARELEU H:41 , CYS H:42 , HIS H:57 , ASP H:189 , SER H:190 , CYS H:191 , LYS H:192 , SER H:195 , VAL H:213 , TRP H:215 , GLY H:216 , GLY H:219 , HOH H:1321 , HOH H:1354 , HOH H:1362BINDING SITE FOR RESIDUE 6NH H 1246

(-) SS Bonds  (12, 12)

Asymmetric/Biological Unit
No.Residues
1H:22 -H:27
2H:42 -H:58
3H:168 -H:182
4H:191 -H:220
5L:50 -L:61
6L:55 -L:70
7L:72 -L:81
8L:91 -L:102
9L:98 -L:112
10L:114 -L:127
11L:135 -H:122
12T:49 -T:57

(-) Cis Peptide Bonds  (2, 2)

Asymmetric/Biological Unit
No.Residues
1Phe H:256 -Pro H:257
2Glu T:26 -Pro T:27

 Sequence-Structure Mapping

(-) SAPs(SNPs)/Variants  (104, 104)

Asymmetric/Biological Unit (104, 104)
  dbSNPPDB
No.SourceVariant IDVariantUniProt IDStatusIDChainVariant
001UniProtVAR_015138G216DFA7_HUMANDisease (FA7D)  ---HG19D
002UniProtVAR_006506C238YFA7_HUMANDisease (FA7D)121964928HC42Y
003UniProtVAR_065387G240RFA7_HUMANDisease (FA7D)  ---HG44R
004UniProtVAR_014413T241NFA7_HUMANDisease (FA7D)  ---HT45N
005UniProtVAR_065388S250FFA7_HUMANDisease (FA7D)  ---HS54F
006UniProtVAR_065389A251PFA7_HUMANDisease (FA7D)  ---HA55P
007UniProtVAR_065390A251TFA7_HUMANDisease (FA7D)  ---HA55T
008UniProtVAR_065376N117DFA7_HUMANDisease (FA7D)121964932LN57D
009UniProtVAR_065391C254RFA7_HUMANDisease (FA7D)  ---HC58R
010UniProtVAR_015139C254YFA7_HUMANDisease (FA7D)  ---HC58Y
011UniProtVAR_015136S120PFA7_HUMANDisease (FA7D)  ---LS60P
012UniProtVAR_014407C121FFA7_HUMANDisease (FA7D)  ---LC61F
013UniProtVAR_065392L264PFA7_HUMANDisease (FA7D)753266903HL64P
014UniProtVAR_014408L125PFA7_HUMANDisease (FA7D)  ---LL65P
015UniProtVAR_015140A266TFA7_HUMANDisease (FA7D)764807079HA66T
016UniProtVAR_014409Y128CFA7_HUMANDisease (FA7D)  ---LY68C
017UniProtVAR_065393D272NFA7_HUMANDisease (FA7D)751028917HD72N
018UniProtVAR_065394D277NFA7_HUMANDisease (FA7D)550074221HD77N
019UniProtVAR_065377G138DFA7_HUMANDisease (FA7D)  ---LG78D
020UniProtVAR_006497R139KFA7_HUMANDisease (FA7D)  ---LR79K
021UniProtVAR_006498R139QFA7_HUMANDisease (FA7D)150525536LR79Q
022UniProtVAR_006499R139WFA7_HUMANDisease (FA7D)776796178LR79W
023UniProtVAR_006507R283WFA7_HUMANDisease (FA7D)779589651HR83W
024UniProtVAR_014410C151SFA7_HUMANDisease (FA7D)  ---LC91S
025UniProtVAR_015137E154KFA7_HUMANDisease (FA7D)146795869LE94K
026UniProtVAR_013936V295DFA7_HUMANPolymorphism6045HV95D
027UniProtVAR_065378G156SFA7_HUMANDisease (FA7D)563972504LG96S
028UniProtVAR_006501G157CFA7_HUMANDisease (FA7D)  ---LG97C
029UniProtVAR_006500G157SFA7_HUMANDisease (FA7D)763458490LG97S
030UniProtVAR_014411G157VFA7_HUMANDisease (FA7D)771335282LG97V
031UniProtVAR_065395T298IFA7_HUMANDisease (FA7D)  ---HT98I
032UniProtVAR_006502Q160RFA7_HUMANDisease (FA7D)200016360LQ100R
033UniProtVAR_065396H301QFA7_HUMANDisease (FA7D)  ---HH101Q
034UniProtVAR_014414D302HFA7_HUMANDisease (FA7D)  ---HD102H
035UniProtVAR_014415D302NFA7_HUMANDisease (FA7D)770328850HD102N
036UniProtVAR_014416A304TFA7_HUMANDisease (FA7D)773627551HA104T
037UniProtVAR_006508A304VFA7_HUMANDisease (FA7D)121964931HA104V
038UniProtVAR_014417R307CFA7_HUMANDisease (FA7D)147680958HR107C
039UniProtVAR_006509R307HFA7_HUMANDisease (FA7D)121964929HR107H
040UniProtVAR_065379S171FFA7_HUMANDisease (FA7D)143855920LS111F
041UniProtVAR_015141V312MFA7_HUMANDisease (FA7D)201991361HV112M
042UniProtVAR_065397L314VFA7_HUMANDisease (FA7D)  ---HL114V
043UniProtVAR_065380G177RFA7_HUMANDisease (FA7D)  ---LG117R
044UniProtVAR_065398L321FFA7_HUMANDisease (FA7D)778138366HL121F
045UniProtVAR_065381L181PFA7_HUMANDisease (FA7D)  ---LL121P
046UniProtVAR_065382D183NFA7_HUMANDisease (FA7D)  ---LD123N
047UniProtVAR_065399L323RFA7_HUMANDisease (FA7D)  ---HL123R
048UniProtVAR_006510E325KFA7_HUMANDisease (FA7D)749760143HE125K
049UniProtVAR_065383S186FFA7_HUMANDisease (FA7D)764971156LS126F
050UniProtVAR_065400R326QFA7_HUMANDisease (FA7D)146698837HR126Q
051UniProtVAR_065384P189SFA7_HUMANDisease (FA7D)  ---LP129S
052UniProtVAR_012008R163WTF_HUMANPolymorphism5901TR131W
053UniProtVAR_065401R337CFA7_HUMANDisease (FA7D)139372641HR134C
054UniProtVAR_065385P194LFA7_HUMANDisease (FA7D)  ---LP134L
055UniProtVAR_006503P194TFA7_HUMANDisease (FA7D)  ---LP134T
056UniProtVAR_014412C195RFA7_HUMANDisease (FA7D)372577568LC135R
057UniProtVAR_006504K197EFA7_HUMANDisease (FA7D)  ---LK137E
058UniProtVAR_015142V341FFA7_HUMANDisease (FA7D)  ---HV138F
059UniProtVAR_065386I198TFA7_HUMANDisease (FA7D)762621913LI138T
060UniProtVAR_065402G343SFA7_HUMANDisease (FA7D)  ---HG140S
061UniProtVAR_076570W344GFA7_HUMANDisease (FA7D)  ---HW141G
062UniProtVAR_065403W344RFA7_HUMANDisease (FA7D)  ---HW141R
063UniProtVAR_065404G345SFA7_HUMANDisease (FA7D)  ---HG142S
064UniProtVAR_065405R350CFA7_HUMANDisease (FA7D)747876824HR147C
065UniProtVAR_013122A352TFA7_HUMANPolymorphism3093267HA150T
066UniProtVAR_006511A354VFA7_HUMANDisease (FA7D)36209567HA152V
067UniProtVAR_006512M358IFA7_HUMANDisease (FA7D)149283257HM156I
068UniProtVAR_006513M358VFA7_HUMANDisease (FA7D)  ---HM156V
069UniProtVAR_065406L360PFA7_HUMANDisease (FA7D)  ---HL158P
070UniProtVAR_065407P363HFA7_HUMANDisease (FA7D)  ---HP161H
071UniProtVAR_015143P363RFA7_HUMANDisease (FA7D)  ---HP161R
072UniProtVAR_006514R364QFA7_HUMANDisease (FA7D)121964926HR162Q
073UniProtVAR_065408R364WFA7_HUMANDisease (FA7D)750980786HR162W
074UniProtVAR_018671T367SFA7_HUMANPolymorphism747673406HT165S
075UniProtVAR_006515C370FFA7_HUMANDisease (FA7D)121964927HC168F
076UniProtVAR_065410T384MFA7_HUMANDisease (FA7D)531225271HT177M
077UniProtVAR_065411M387TFA7_HUMANDisease (FA7D)  ---HM180T
078UniProtVAR_065412M387VFA7_HUMANDisease (FA7D)  ---HM180V
079UniProtVAR_065413F388SFA7_HUMANDisease (FA7D)121964938HF181S
080UniProtVAR_014392C389GFA7_HUMANDisease (FA7D)121964934HC182G
081UniProtVAR_065415D398EFA7_HUMANDisease (FA7D)  ---HD189E
082UniProtVAR_065416K401EFA7_HUMANDisease (FA7D)748979195HK192E
083UniProtVAR_006517G402EFA7_HUMANDisease (FA7D)  ---HG193E
084UniProtVAR_006516G402RFA7_HUMANDisease (FA7D)  ---HG193R
085UniProtVAR_015144D403HFA7_HUMANDisease (FA7D)  ---HD194H
086UniProtVAR_065417S404NFA7_HUMANDisease (FA7D)  ---HS195N
087UniProtVAR_065418H408QFA7_HUMANDisease (FA7D)121964936HH199Q
088UniProtVAR_065419H408RFA7_HUMANDisease (FA7D)  ---HH199R
089UniProtVAR_065420R413GFA7_HUMANDisease (FA7D)  ---HR204G
090UniProtVAR_006518R413QFA7_HUMANPolymorphism6046HR204Q
091UniProtVAR_065421G414CFA7_HUMANDisease (FA7D)121964937HG205C
092UniProtVAR_006519T419MFA7_HUMANDisease (FA7D)121964930HT210M
093UniProtVAR_065422V422FFA7_HUMANDisease (FA7D)  ---HV213F
094UniProtVAR_065423G425AFA7_HUMANDisease (FA7D)  ---HG216A
095UniProtVAR_065424G425CFA7_HUMANDisease (FA7D)  ---HG216C
096UniProtVAR_065426G432DFA7_HUMANDisease (FA7D)  ---HG223D
097UniProtVAR_014420G435EFA7_HUMANDisease (FA7D)756956471HG226E
098UniProtVAR_065427Y437FFA7_HUMANDisease (FA7D)758213652HY228F
099UniProtVAR_013123E445KFA7_HUMANPolymorphism3093248HE236K
100UniProtVAR_014418T332MFA7_HUMANDisease (FA7D)200212201HT129CM
101UniProtVAR_065409R375WFA7_HUMANDisease (FA7D)137919286HR170CW
102UniProtVAR_065414G391CFA7_HUMANDisease (FA7D)  ---HG184AC
103UniProtVAR_014419G391SFA7_HUMANDisease (FA7D)190485816HG184AS
104UniProtVAR_065425A429TFA7_HUMANDisease (FA7D)755377592HA221AT

  SNP/SAP Summary Statistics (UniProtKB/Swiss-Prot)

(-) PROSITE Motifs  (7, 7)

Asymmetric/Biological Unit (7, 7)
 PROSITEUniProtKBPDB
No.IDACDescriptionIDLocationCountLocation
1TISSUE_FACTORPS00621 Tissue factor signature.TF_HUMAN77-94  1T:45-62
2ASX_HYDROXYLPS00010 Aspartic acid and asparagine hydroxylation site.FA7_HUMAN121-132  1L:61-72
3EGF_1PS00022 EGF-like domain signature 1.FA7_HUMAN130-141  1L:70-81
4EGF_2PS01186 EGF-like domain signature 2.FA7_HUMAN172-187  1L:112-127
5TRYPSIN_DOMPS50240 Serine proteases, trypsin domain profile.FA7_HUMAN213-452  1H:16-243
6TRYPSIN_HISPS00134 Serine proteases, trypsin family, histidine active site.FA7_HUMAN249-254  1H:53-58
7TRYPSIN_SERPS00135 Serine proteases, trypsin family, serine active site.FA7_HUMAN398-409  1H:189-200

(-) Exons   (9, 10)

Asymmetric/Biological Unit (9, 10)
 ENSEMBLUniProtKBPDB
No.Transcript IDExonExon IDGenome LocationLengthIDLocationLengthCountLocationLength
1.1aENST000003340471aENSE00001452073chr1:95007356-95007093264TF_HUMAN1-34340--
1.3ENST000003340473ENSE00000777349chr1:95005924-95005813112TF_HUMAN34-71381T:6-3934
1.4ENST000003340474ENSE00001329748chr1:95001720-95001521200TF_HUMAN71-138681T:39-10668
1.5bENST000003340475bENSE00000777351chr1:94998824-94998646179TF_HUMAN138-197601T:106-157 (gaps)52
1.6ENST000003340476ENSE00000777352chr1:94998036-94997877160TF_HUMAN198-251541T:188-20518
1.7bENST000003340477bENSE00001906129chr1:94996152-949947811372TF_HUMAN251-295450--

2.1bENST000003755811bENSE00001891092chr13:113760121-11376021999FA7_HUMAN1-22220--
2.2ENST000003755812ENSE00000862519chr13:113761159-11376122466FA7_HUMAN22-44230--
2.3cENST000003755813cENSE00001135032chr13:113765004-113765164161FA7_HUMAN44-97540--
2.4aENST000003755814aENSE00000862522chr13:113768066-11376809025FA7_HUMAN98-10690--
2.4cENST000003755814cENSE00001135014chr13:113768161-113768274114FA7_HUMAN106-144391-
L:47-84
-
38
2.7ENST000003755817ENSE00001786842chr13:113769974-113770114141FA7_HUMAN144-191481-
L:84-131
-
48
2.8cENST000003755818cENSE00001134999chr13:113771080-113771189110FA7_HUMAN191-227372H:16-30
L:131-142
15
12
2.9ENST000003755819ENSE00000687189chr13:113771787-113771910124FA7_HUMAN228-269421H:31-69 (gaps)
-
43
-
2.10bENST0000037558110bENSE00001467515chr13:113772727-1137749952269FA7_HUMAN269-4661981H:69-257 (gaps)
-
208
-

(-) Sequences/Alignments

Asymmetric/Biological Unit
   Reformat: Number of residues per line =  ('0' or empty: single-line sequence representation)
  Number of residues per labelling interval =   
  UniProt sequence: complete  aligned part    
   Show mapping: SCOP domains CATH domains Pfam domains Secondary structure (by author)
SAPs(SNPs) PROSITE motifs Exons
(details for a mapped element are shown in a popup box when the mouse pointer rests over it)
Chain H from PDB  Type:PROTEIN  Length:254
 aligned with FA7_HUMAN | P08709 from UniProtKB/Swiss-Prot  Length:466

    Alignment length:254
                                   222       232       242       252       262       272       282       292       302       312       322       332       342       352       362       372       382       392       402       412       422       432       442       452       462    
           FA7_HUMAN    213 IVGGKVCPKGECPWQVLLLVNGAQLCGGTLINTIWVVSAAHCFDKIKNWRNLIAVLGEHDLSEHDGDEQSRRVAQVIIPSTYVPGTTNHDIALLRLHQPVVLTDHVVPLCLPERTFSERTLAFVRFSLVSGWGQLLDRGATALELMVLNVPRLMTQDCLQQSRKVGDSPNITEYMFCAGYSDGSKDSCKGDSGGPHATHYRGTWYLTGIVSWGQGCATVGHFGVYTRVSQYIEWLQKLMRSEPRPGVLLRAPFP  466
               SCOP domains d2flbh_ H: Coagulation factor VIIa                                                                                                                                                                                                                             SCOP domains
               CATH domains 2flbH01     2flbH02 H:28-120,H:233-246 Trypsin-like serine proteases                                        2flbH01 H:16-27,H:121-232 Trypsin-like serine proteases                                                                  2flbH02       ----------- CATH domains
               Pfam domains -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- Pfam domains
         Sec.struct. author ....ee........eeeeee..eeeeeeeeee..eeeehhhhhh...hhh.eeeee............eeeeeeeeeee............eeeee................hhhhhhhhhhhh.eeeeee..............eeeeeeeehhhhhhhhh............eeee................eeeeee..eeeeeeeeee..........eeeee...hhhhhhhhhhh......eeee... Sec.struct. author
             SAPs(SNPs) (1) ---D---------------------Y-RN--------FP--R---------P-T-----N----N-----W-----------D--I--QH-T--C----M-V------F-R-KQ-----M----C---F-SGS----C-T-V---I-P--HQ--S--F----W--------M--TSG-C------E--EEHN---Q----GC----M--F--A---T--D--E-F-------K--------------------- SAPs(SNPs) (1)
             SAPs(SNPs) (2) --------------------------------------T--Y-----------------------------------------------N-V--H------------------------------------R-------------V----RW----------------------V---S----------R-----R----Q-----------C----------------------------------------- SAPs(SNPs) (2)
                PROSITE (1) TRYPSIN_DOM  PDB: H:16-243 UniProt: 213-452                                                                                                                                                                                                     -------------- PROSITE (1)
                PROSITE (2) ------------------------------------TRYPSI-----------------------------------------------------------------------------------------------------------------------------------------------TRYPSIN_SER --------------------------------------------------------- PROSITE (2)
           Transcript 2 (1) Exon 2.8c      -----------------------------------------Exon 2.10b  PDB: H:69-257 (gaps) UniProt: 269-466                                                                                                                                                      Transcript 2 (1)
           Transcript 2 (2) ---------------Exon 2.9  PDB: H:31-69 (gaps)             ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- Transcript 2 (2)
                2flb H   16 IVGGKVCPKGECPWQVLLLVNGAQLCGGTLINTIWVVSAAHCFDKIKNWRNLIAVLGEHDLSEHDGDEQSRRVAQVIIPSTYVPGTTNHDIALLRLHQPVVLTDHVVPLCLPERTFSERTLAFVRFSLVSGWGQLLDRGATALELMVLNVPRLMTQDCLQQSRKVGDSPNITEYMFCAGYSDGSKDSCKGDSGGPHATHYRGTWYLTGIVSWGQGCATVGHFGVYTRVSQYIEWLQKLMRSEPRPGVLLRAPFP  257
                                    25        35|       46        56    ||||62        72        82        92       102       112       122      129C|||||  139       150       160       170|||||||175       184   |   193       203       213   || |223       233       243       253    
                                              35|                     60A|||                                                                  129A|||||||          147|                  170A||||||175     184A 188A                           217| |                                     
                                               37                      60B||                                                                   129B||||||           149                   170B|||||||                                           219 |                                     
                                                                        60C|                                                                    129C|||||                                  170C||||||                                            221A                                     
                                                                         60D                                                                     129D||||                                   170D|||||                                                                                     
                                                                                                                                                  129E|||                                    170E||||                                                                                     
                                                                                                                                                   129F||                                     170F|||                                                                                     
                                                                                                                                                    129G|                                      170G||                                                                                     
                                                                                                                                                      134                                       170H|                                                                                     
                                                                                                                                                                                                 170I                                                                                     

Chain L from PDB  Type:PROTEIN  Length:96
 aligned with FA7_HUMAN | P08709 from UniProtKB/Swiss-Prot  Length:466

    Alignment length:96
                                   116       126       136       146       156       166       176       186       196      
           FA7_HUMAN    107 GDQCASSPCQNGGSCKDQLQSYICFCLPAFEGRNCETHKDDQLICVNENGGCEQYCSDHTGTKRSCRCHEGYSLLADGVSCTPTVEYPCGKIPILE  202
               SCOP domains d2flbl1 L:47-86 Coagulation factor VIIa d2flbl2 L:87-142 Coagulation factor VIIa                 SCOP domains
               CATH domains 2flbL01 L:47-88 Laminin                   2flbL02 L:89-142 Laminin                               CATH domains
               Pfam domains ------------------------------------------------------------------------------------------------ Pfam domains
         Sec.struct. author ..hhhhh......eeee....eeee....ee.....ee.hhh....hhhhhh..eeeee..eeeeee....eee......eee........hhhhh Sec.struct. author
             SAPs(SNPs) (1) ----------D--PF---P--C---------DK-----------S--K-SC--R----------F-----R---P-N--F--S----LR-ET---- SAPs(SNPs) (1)
             SAPs(SNPs) (2) --------------------------------Q-----------------S------------------------------------T-------- SAPs(SNPs) (2)
             SAPs(SNPs) (3) --------------------------------W-----------------V--------------------------------------------- SAPs(SNPs) (3)
                PROSITE (1) --------------ASX_HYDROXYL---------------------------------------EGF_2           --------------- PROSITE (1)
                PROSITE (2) -----------------------EGF_1       ------------------------------------------------------------- PROSITE (2)
           Transcript 2 (1) Exon 2.4c  PDB: L:47-84 [INCOMPLETE]  ----------------------------------------------Exon 2.8c    Transcript 2 (1)
           Transcript 2 (2) -------------------------------------Exon 2.7  PDB: L:84-131 UniProt: 144-191        ----------- Transcript 2 (2)
                2flb L   47 GDQCASSPCQNGGSCKDQLQSYICFCLPAFEGRNCETHKDDQLICVNENGGCEQYCSDHTGTKRSCRCHEGYSLLADGVSCTPTVEYPCGKIPILE  142
                                    56        66        76        86        96       106       116       126       136      

Chain T from PDB  Type:PROTEIN  Length:151
 aligned with TF_HUMAN | P13726 from UniProtKB/Swiss-Prot  Length:295

    Alignment length:200
                                    47        57        67        77        87        97       107       117       127       137       147       157       167       177       187       197       207       217       227       237
            TF_HUMAN     38 TVAAYNLTWKSTNFKTILEWEPKPVNQVYTVQISTKSGDWKSKCFYTTDTECDLTDEIVKDVKQTYLARVFSYPAGNVESTGSAGEPLYENSPEFTPYLETNLGQPTIQSFEQVGTKVNVTVEDERTLVRRNNTFLSLRDVFGKDLIYTLYYWKSSSSGKKTAKTNTNEFLIDVDKGENYCFSVQAVIPSRTVNRKSTDS  237
               SCOP domains d2flbt1 T:6-106 Extracellular region of human tissue factor                                          d2f                   lbt2 T:107-205 Extracellular                               region of human ti SCOP domains
               CATH domains 2flbT00 T:6-205 Immunoglobulins                                                                                                                                                                          CATH domains
               Pfam domains -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- Pfam domains
         Sec.struct. author ....eeeeeeee..eeeeeee.....eeeeeeeee.....eeeeeee...eeehhhhhh......eeeeeeeee.............eeee....hhhhhh...-------------------..eeeeee..eeeehhhhhh...eee...------------------------------..eee............. Sec.struct. author
                 SAPs(SNPs) -----------------------------------------------------------------------------------------------------------------------------W-------------------------------------------------------------------------- SAPs(SNPs)
                    PROSITE ---------------------------------------TISSUE_FACTOR     ----------------------------------------------------------------------------------------------------------------------------------------------- PROSITE
           Transcript 1 (1) Exon 1.3  PDB: T:6-39 [INCOMPLETE]------------------------------------------------------------------Exon 1.5b  PDB: T:106-157 (gaps) UniProt: 138-197           Exon 1.6  PDB: T:188-205 [INCOMPLETE]    Transcript 1 (1)
           Transcript 1 (2) ---------------------------------Exon 1.4  PDB: T:39-106 UniProt: 71-138                             --------------------------------------------------------------------------------------------------- Transcript 1 (2)
                2flb T    6 TVAAYNLTWKSTNFKTILEWEPKPVNQVYTVQISTKSGDWKSKCFYTTDTECDLTDEIVKDVKQTYLARVFSYPAGNVESTGSAGEPLYENSPEFTPYLETNLG-------------------DERTLVRRNNTFLSLRDVFGKDLIYTLYY------------------------------SVQAVIPSRTVNRKSTDS  205
                                    15        25        35        45        55        65        75        85        95       105   |     -         -   |   135       145       155 |       -         -         -  |    195       205
                                                                                                                                 109                 129                         157                            188                 

   Legend:   → Mismatch (orange background)
  - → Gap (green background, '-', border residues have a numbering label)
    → Modified Residue (blue background, lower-case, 'x' indicates undefined single-letter code, labelled with number + name)
  x → Chemical Group (purple background, 'x', labelled with number + name, e.g. ACE or NH2)
  extra numbering lines below/above indicate numbering irregularities and modified residue names etc., number ends below/above '|'

 Classification and Annotation

(-) SCOP Domains  (3, 5)

Asymmetric/Biological Unit

(-) CATH Domains  (3, 5)

Asymmetric/Biological Unit
(-)
Class: Mainly Beta (13760)

(-) Pfam Domains  (0, 0)

(no "Pfam Domain" information available for 2FLB)

(-) Gene Ontology  (61, 72)

Asymmetric/Biological Unit(hide GO term definitions)
Chain H,L   (FA7_HUMAN | P08709)
molecular function
    GO:0005509    calcium ion binding    Interacting selectively and non-covalently with calcium ions (Ca2+).
    GO:0004175    endopeptidase activity    Catalysis of the hydrolysis of internal, alpha-peptide bonds in a polypeptide chain.
    GO:0016787    hydrolase activity    Catalysis of the hydrolysis of various bonds, e.g. C-O, C-N, C-C, phosphoric anhydride bonds, etc. Hydrolase is the systematic name for any enzyme of EC class 3.
    GO:0008233    peptidase activity    Catalysis of the hydrolysis of a peptide bond. A peptide bond is a covalent bond formed when the carbon atom from the carboxyl group of one amino acid shares electrons with the nitrogen atom from the amino group of a second amino acid.
    GO:0005515    protein binding    Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules).
    GO:0005102    receptor binding    Interacting selectively and non-covalently with one or more specific sites on a receptor molecule, a macromolecule that undergoes combination with a hormone, neurotransmitter, drug or intracellular messenger to initiate a change in cell function.
    GO:0004252    serine-type endopeptidase activity    Catalysis of the hydrolysis of internal, alpha-peptide bonds in a polypeptide chain by a catalytic mechanism that involves a catalytic triad consisting of a serine nucleophile that is activated by a proton relay involving an acidic residue (e.g. aspartate or glutamate) and a basic residue (usually histidine).
    GO:0008236    serine-type peptidase activity    Catalysis of the hydrolysis of peptide bonds in a polypeptide chain by a catalytic mechanism that involves a catalytic triad consisting of a serine nucleophile that is activated by a proton relay involving an acidic residue (e.g. aspartate or glutamate) and a basic residue (usually histidine).
biological process
    GO:0006888    ER to Golgi vesicle-mediated transport    The directed movement of substances from the endoplasmic reticulum (ER) to the Golgi, mediated by COP II vesicles. Small COP II coated vesicles form from the ER and then fuse directly with the cis-Golgi. Larger structures are transported along microtubules to the cis-Golgi.
    GO:0031100    animal organ regeneration    The regrowth of a lost or destroyed animal organ.
    GO:0007596    blood coagulation    The sequential process in which the multiple coagulation factors of the blood interact, ultimately resulting in the formation of an insoluble fibrin clot; it may be divided into three stages: stage 1, the formation of intrinsic and extrinsic prothrombin converting principle; stage 2, the formation of thrombin; stage 3, the formation of stable fibrin polymers.
    GO:0007598    blood coagulation, extrinsic pathway    A protein activation cascade that contributes to blood coagulation and consists of the self-limited process linking exposure and activation of tissue factor to the activation of clotting factor X.
    GO:0007623    circadian rhythm    Any biological process in an organism that recurs with a regularity of approximately 24 hours.
    GO:0007599    hemostasis    The stopping of bleeding (loss of body fluid) or the arrest of the circulation to an organ or part.
    GO:0017187    peptidyl-glutamic acid carboxylation    The gamma-carboxylation of peptidyl-glutamic acid; catalyzed by the vitamin K dependent gamma-glutamyl carboxylase.
    GO:0030194    positive regulation of blood coagulation    Any process that activates or increases the frequency, rate or extent of blood coagulation.
    GO:0030335    positive regulation of cell migration    Any process that activates or increases the frequency, rate or extent of cell migration.
    GO:0002690    positive regulation of leukocyte chemotaxis    Any process that activates or increases the frequency, rate, or extent of leukocyte chemotaxis.
    GO:0010641    positive regulation of platelet-derived growth factor receptor signaling pathway    Any process that increases the frequency, rate or extent of the platelet-derived growth factor receptor signaling pathway.
    GO:0050927    positive regulation of positive chemotaxis    Any process that activates or increases the frequency, rate or extent of the directed movement of a motile cell or organism towards a higher concentration in a concentration gradient of a specific chemical.
    GO:0051897    positive regulation of protein kinase B signaling    Any process that activates or increases the frequency, rate or extent of protein kinase B signaling, a series of reactions mediated by the intracellular serine/threonine kinase protein kinase B.
    GO:0006508    proteolysis    The hydrolysis of proteins into smaller polypeptides and/or amino acids by cleavage of their peptide bonds.
    GO:0043627    response to estrogen    Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of stimulus by an estrogen, C18 steroid hormones that can stimulate the development of female sexual characteristics.
    GO:0060416    response to growth hormone    Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a growth hormone stimulus. Growth hormone is a peptide hormone that binds to the growth hormone receptor and stimulates growth.
    GO:0009725    response to hormone    Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a hormone stimulus.
    GO:0031667    response to nutrient levels    Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus reflecting the presence, absence, or concentration of nutrients.
    GO:0014070    response to organic cyclic compound    Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an organic cyclic compound stimulus.
    GO:0032571    response to vitamin K    Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a vitamin K stimulus.
    GO:0006465    signal peptide processing    The proteolytic removal of a signal peptide from a protein during or after transport to a specific location in the cell.
cellular component
    GO:0005796    Golgi lumen    The volume enclosed by the membranes of any cisterna or subcompartment of the Golgi apparatus, including the cis- and trans-Golgi networks.
    GO:0005788    endoplasmic reticulum lumen    The volume enclosed by the membranes of the endoplasmic reticulum.
    GO:0005576    extracellular region    The space external to the outermost structure of a cell. For cells without external protective or external encapsulating structures this refers to space outside of the plasma membrane. This term covers the host cell environment outside an intracellular parasite.
    GO:0005615    extracellular space    That part of a multicellular organism outside the cells proper, usually taken to be outside the plasma membranes, and occupied by fluid.
    GO:0005886    plasma membrane    The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins.
    GO:0031982    vesicle    Any small, fluid-filled, spherical organelle enclosed by membrane.

Chain T   (TF_HUMAN | P13726)
molecular function
    GO:0004896    cytokine receptor activity    Combining with a cytokine and transmitting the signal from one side of the membrane to the other to initiate a change in cell activity.
    GO:0005543    phospholipid binding    Interacting selectively and non-covalently with phospholipids, a class of lipids containing phosphoric acid as a mono- or diester.
    GO:0002020    protease binding    Interacting selectively and non-covalently with any protease or peptidase.
    GO:0005515    protein binding    Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules).
biological process
    GO:0002543    activation of blood coagulation via clotting cascade    Any process that initiates the clotting cascade of blood coagulation, a cascade of plasma enzymes that is triggered following damage to blood vessels, leading to formation of a clot.
    GO:0006919    activation of cysteine-type endopeptidase activity involved in apoptotic process    Any process that initiates the activity of the inactive enzyme cysteine-type endopeptidase in the context of an apoptotic process.
    GO:0002541    activation of plasma proteins involved in acute inflammatory response    Any process activating plasma proteins by proteolysis as part of an acute inflammatory response.
    GO:0007568    aging    A developmental process that is a deterioration and loss of function over time. Aging includes loss of functions such as resistance to disease, homeostasis, and fertility, as well as wear and tear. Aging includes cellular senescence, but is more inclusive. May precede death and may succeed developmental maturation (GO:0021700).
    GO:0007596    blood coagulation    The sequential process in which the multiple coagulation factors of the blood interact, ultimately resulting in the formation of an insoluble fibrin clot; it may be divided into three stages: stage 1, the formation of intrinsic and extrinsic prothrombin converting principle; stage 2, the formation of thrombin; stage 3, the formation of stable fibrin polymers.
    GO:0007598    blood coagulation, extrinsic pathway    A protein activation cascade that contributes to blood coagulation and consists of the self-limited process linking exposure and activation of tissue factor to the activation of clotting factor X.
    GO:0070301    cellular response to hydrogen peroxide    Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a hydrogen peroxide (H2O2) stimulus.
    GO:0019221    cytokine-mediated signaling pathway    A series of molecular signals initiated by the binding of a cytokine to a receptor on the surface of a cell, and ending with regulation of a downstream cellular process, e.g. transcription.
    GO:0007599    hemostasis    The stopping of bleeding (loss of body fluid) or the arrest of the circulation to an organ or part.
    GO:0045766    positive regulation of angiogenesis    Any process that activates or increases angiogenesis.
    GO:0030335    positive regulation of cell migration    Any process that activates or increases the frequency, rate or extent of cell migration.
    GO:0001938    positive regulation of endothelial cell proliferation    Any process that activates or increases the rate or extent of endothelial cell proliferation.
    GO:0010641    positive regulation of platelet-derived growth factor receptor signaling pathway    Any process that increases the frequency, rate or extent of the platelet-derived growth factor receptor signaling pathway.
    GO:0050927    positive regulation of positive chemotaxis    Any process that activates or increases the frequency, rate or extent of the directed movement of a motile cell or organism towards a higher concentration in a concentration gradient of a specific chemical.
    GO:0051897    positive regulation of protein kinase B signaling    Any process that activates or increases the frequency, rate or extent of protein kinase B signaling, a series of reactions mediated by the intracellular serine/threonine kinase protein kinase B.
    GO:0014911    positive regulation of smooth muscle cell migration    Any process that activates, maintains or increases the frequency, rate or extent of smooth muscle cell migration.
    GO:0032355    response to estradiol    Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of stimulus by estradiol, a C18 steroid hormone hydroxylated at C3 and C17 that acts as a potent estrogen.
    GO:0034405    response to fluid shear stress    Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a fluid shear stress stimulus. Fluid shear stress is the force acting on an object in a system where the fluid is moving across a solid surface.
    GO:0032496    response to lipopolysaccharide    Any process that results in a change in state or activity of an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a lipopolysaccharide stimulus; lipopolysaccharide is a major component of the cell wall of gram-negative bacteria.
    GO:0055098    response to low-density lipoprotein particle stimulus    Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a low-density lipoprotein particle stimulus.
    GO:0009612    response to mechanical stimulus    Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a mechanical stimulus.
    GO:0009266    response to temperature stimulus    Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a temperature stimulus.
    GO:0009611    response to wounding    Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus indicating damage to the organism.
cellular component
    GO:0009986    cell surface    The external part of the cell wall and/or plasma membrane.
    GO:0005737    cytoplasm    All of the contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.
    GO:0070062    extracellular exosome    A vesicle that is released into the extracellular region by fusion of the limiting endosomal membrane of a multivesicular body with the plasma membrane. Extracellular exosomes, also simply called exosomes, have a diameter of about 40-100 nm.
    GO:0031012    extracellular matrix    A structure lying external to one or more cells, which provides structural support for cells or tissues.
    GO:0005576    extracellular region    The space external to the outermost structure of a cell. For cells without external protective or external encapsulating structures this refers to space outside of the plasma membrane. This term covers the host cell environment outside an intracellular parasite.
    GO:0005615    extracellular space    That part of a multicellular organism outside the cells proper, usually taken to be outside the plasma membranes, and occupied by fluid.
    GO:0016021    integral component of membrane    The component of a membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane.
    GO:0031233    intrinsic component of external side of plasma membrane    The component of a plasma membrane consisting of gene products and protein complexes that penetrate the external side of the plasma membrane only, either directly or via some covalently attached hydrophobic anchor.
    GO:0016020    membrane    A lipid bilayer along with all the proteins and protein complexes embedded in it an attached to it.
    GO:0005886    plasma membrane    The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins.

 Visualization

(-) Interactive Views

Asymmetric/Biological Unit
  Complete Structure
    Jena3D(integrated viewing of ligand, site, SAP, PROSITE, SCOP information)
    WebMol | AstexViewer[tm]@PDBe
(Java Applets, require no local installation except for Java; loading may be slow)
    STRAP
(Java WebStart application, automatic local installation, requires Java; full application with system access!)
    RasMol
(require local installation)
    Molscript (VRML)
(requires installation of a VRML viewer; select preferred view via VRML and generate a mono or stereo PDF format file)
 
  Ligands, Modified Residues, Ions
    6NH  [ RasMol | Jena3D ]  +environment [ RasMol | Jena3D ]
 
  Sites
    AC1  [ RasMol ]  +environment [ RasMol ]
 
  Cis Peptide Bonds
    Glu T:26 - Pro T:27   [ RasMol ]  
    Phe H:256 - Pro H:257   [ RasMol ]  
 

(-) Still Images

Jmol
  protein: cartoon or spacefill or dots and stick; nucleic acid: cartoon and stick; ligands: spacefill; active site: stick
Molscript
  protein, nucleic acid: cartoon; ligands: spacefill; active site: ball and stick

 Databases and Analysis Tools

(-) Databases

Access by PDB/NDB ID
  2flb
    Family and Domain InformationProDom | SYSTERS
    General Structural InformationGlycoscienceDB | MMDB | NDB | OCA | PDB | PDBe | PDBj | PDBsum | PDBWiki | PQS | PROTEOPEDIA
    Orientation in MembranesOPM
    Protein SurfaceSURFACE
    Secondary StructureDSSP (structure derived) | HSSP (homology derived)
    Structural GenomicsGeneCensus
    Structural NeighboursCE | VAST
    Structure ClassificationCATH | Dali | SCOP
    Validation and Original DataBMRB Data View | BMRB Restraints Grid | EDS | PROCHECK | RECOORD | WHAT_CHECK
 
Access by UniProt ID/Accession number
  FA7_HUMAN | P08709
    Comparative Protein Structure ModelsModBase
    Genomic InformationEnsembl
    Protein-protein InteractionDIP
    Sequence, Family and Domain InformationInterPro | Pfam | SMART | UniProtKB/SwissProt
  TF_HUMAN | P13726
    Comparative Protein Structure ModelsModBase
    Genomic InformationEnsembl
    Protein-protein InteractionDIP
    Sequence, Family and Domain InformationInterPro | Pfam | SMART | UniProtKB/SwissProt
 
Access by Enzyme Classificator   (EC Number)
  (no 'Enzyme Classificator' available)
    General Enzyme InformationBRENDA | EC-PDB | Enzyme | IntEnz
    PathwayKEGG | MetaCyc
 
Access by Disease Identifier   (MIM ID)
  227500
    Disease InformationOMIM
 
Access by GenAge ID
  (no 'GenAge ID' available)
    Age Related InformationGenAge

(-) Analysis Tools

Access by PDB/NDB ID
    Domain InformationXDom
    Interatomic Contacts of Structural UnitsCSU
    Ligand-protein ContactsLPC
    Protein CavitiescastP
    Sequence and Secondary StructurePDBCartoon
    Structure AlignmentSTRAP(Java WebStart application, automatic local installation, requires Java; full application with system access!)
    Structure and Sequence BrowserSTING
 
Access by UniProt ID/Accession number
  FA7_HUMAN | P08709
    Protein Disorder PredictionDisEMBL | FoldIndex | GLOBPLOT (for more information see DisProt)
  TF_HUMAN | P13726
    Protein Disorder PredictionDisEMBL | FoldIndex | GLOBPLOT (for more information see DisProt)

 Related Entries

(-) Entries Sharing at Least One Protein Chain (UniProt ID)

UniProtKB/Swiss-Prot
        FA7_HUMAN | P087091bf9 1cvw 1dan 1dva 1f7e 1f7m 1fak 1ff7 1ffm 1j9c 1jbu 1kli 1klj 1nl8 1o5d 1qfk 1w0y 1w2k 1w7x 1w8b 1wqv 1wss 1wtg 1wun 1wv7 1ygc 1z6j 2a2q 2aei 2aer 2b7d 2b8o 2bz6 2c4f 2ec9 2f9b 2fir 2flr 2puq 2zp0 2zwl 2zzu 3ela 3th2 3th3 3th4 4ibl 4ish 4isi 4jyu 4jyv 4jzd 4jze 4jzf 4na9 4ng9 4nga 4x8s 4x8t 4x8u 4x8v 4ylq 4yt6 4yt7 4z6a 4zma 4zxx 4zxy 5i46 5l2y 5l2z 5l30 5pa8 5pa9 5paa 5pab 5pac 5pae 5paf 5pag 5pai 5paj 5pak 5pam 5pan 5pao 5paq 5par 5pas 5pat 5pau 5pav 5paw 5pax 5pay 5pb0 5pb1 5pb2 5pb3 5pb4 5pb5 5pb6 5tqe 5tqf 5tqg 5u6j
        TF_HUMAN | P137261ahw 1boy 1dan 1fak 1j9c 1jps 1nl8 1o5d 1tfh 1uj3 1w0y 1w2k 1wqv 1wss 1wtg 1wun 1wv7 1z6j 2a2q 2aei 2aer 2b7d 2b8o 2c4f 2cef 2ceh 2cez 2cfj 2ec9 2f9b 2fir 2flr 2hft 2puq 2zp0 2zwl 2zzu 3ela 3th2 3th3 3th4 4ibl 4m7l 4ylq 4z6a 4zma 5w06

(-) Related Entries Specified in the PDB File

1o5d CRYSTAL STRUCTURE OF FACTOR VIIA-TISSUE FACTOR-INHIBITOR COMPLEX